Redcare Pharmacy raises 2026 revenue growth forecast to 15%-17%

Reuters2026/07/30 10:23

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Redcare raised 2026 guidance in June, targeting total revenue growth of 15%-17% versus 13%-15% previously.
Germany Rx revenue forecast lifted to EUR 680 million-EUR 720 million from more than EUR 670 million, driven mainly by higher basket sizes.
Non-Rx growth outlook increased to 10%-12% from 8%-10%.
Adjusted EBITDA margin now seen at 2.5%-3% from more than 2.5%, backed by strong Q2 trading, operating leverage, efficiency gains.
Management flagged softer July trading, with group growth expected below 20% and single-digit non-Rx growth in Germany.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Redcare Pharmacy NV published the original content used to generate this news brief on July 30, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Redcare Pharmacy raises 2026 revenue growth forecast to 15%-17%

You may also like

Crypto prices